NCT07690293

Brief Summary

This randomized, double-blind, parallel-group controlled clinical trial aims to evaluate the effects of traditional Chinese medicine patch application at the Shenque (RN8) acupoint on cancer-related fatigue in adult cancer patients scheduled to undergo radiotherapy. Eligible participants will be randomly assigned to receive either a traditional Chinese medicine patch or a sham patch at the same acupoint. The intervention will be applied once daily for 2 hours, 7 days per week, for 2 consecutive weeks, for a total of 14 sessions. Fatigue severity, quality of life, heart rate variability, complete blood count, and skin safety will be assessed before and after the intervention.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Aug 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 8, 2026

Completed
24 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

July 24, 2026

Status Verified

July 1, 2026

Enrollment Period

12 months

First QC Date

July 2, 2026

Last Update Submit

July 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Fatigue Severity Assessed by Visual Analog Scale From Baseline to End of Intervention

    Baseline and approximately 2 weeks

Secondary Outcomes (4)

  • Change in Quality of Life Assessed by Functional Assessment of Cancer Therapy-General From Baseline to End of Intervention

    Baseline and approximately 2 weeks

  • Change in Heart Rate Variability From Baseline to End of Intervention

    Baseline and approximately 2 weeks

  • Change in Complete Blood Count Parameters From Baseline to End of Intervention

    Baseline and approximately 2 weeks

  • Incidence of Skin Reactions at the Patch Application Site

    During the 2-week intervention

Study Arms (2)

Traditional Chinese Medicine Patch

EXPERIMENTAL

Participants in this arm will receive traditional Chinese medicine patch application at the Shenque (RN8) acupoint once daily for 2 hours, 7 days per week, for 2 consecutive weeks, for a total of 14 sessions.

Other: Traditional Chinese Medicine Patch

Sham Patch

SHAM COMPARATOR

Participants in this arm will receive a sham patch at the Shenque (RN8) acupoint using the same frequency and duration as the experimental group. The sham patch will be made with flour and caramel coloring instead of traditional Chinese medicine powder.

Other: Sham Patch

Interventions

The sham patch will be applied at the Shenque (RN8) acupoint using the same frequency and duration as the experimental intervention. The sham patch will be made with 5 g of flour and caramel coloring instead of traditional Chinese medicine powder.

Sham Patch

The traditional Chinese medicine patch will be applied at the Shenque (RN8) acupoint once daily for 2 hours, 7 days per week, for 2 consecutive weeks, for a total of 14 sessions. The patch will be prepared by mixing 5 g of traditional Chinese medicine powder with 7 g of water and applying the mixture to gauze or a patch.

Traditional Chinese Medicine Patch

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 20 years or older.
  • Patients diagnosed with cancer by a physician.
  • Patients scheduled to undergo radiotherapy.
  • Patients who meet the diagnostic criteria for cancer-related fatigue and have a fatigue scale score of 4 or higher.
  • Patients who are willing and able to provide written informed consent after receiving an explanation of the study procedures and possible risks.

You may not qualify if:

  • Patients who are not suitable for traditional Chinese medicine patch application, including those with wounds or skin lesions at the acupoint application site.
  • Patients who are unwilling to sign the informed consent form.
  • Minors, pregnant women, patients with psychiatric disorders, or vulnerable populations.
  • Patients with diseases that may affect heart rate variability.
  • Patients who have received astragalus polysaccharide injection within 1 month before the start of the study.
  • Patients who have used Chinese herbal medicine within 1 month before the start of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2026

First Posted

July 8, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

July 24, 2026

Record last verified: 2026-07